Extra-Neurological Characterization of Seckel Syndrome-Model Mice Harboring CEP152 Variants
Cells · 24.06.2026 · 15 (13) · 1148
DOI: 10.3390/cells15131148 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 24.06.2026. Verfasst von Nanako Hamada und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Neurobiology, Institute for Developmental Research, Aichi Developmental Disability Center, Kasugai 480-0392, Japan. Hauptthemen laut MEDLINE: Centrosomal Associated Proteins, Microcephaly, Dwarfism, Cell Cycle Proteins. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Daiko Foundation, Japan Foundation for Pediatric Research.
Abstract (Originalsprache)
Centrosomal protein 152 (CEP152) is a key regulator of centriole architecture and function, essential for proper cell division and polarity. Pathogenic variants in CEP152 cause Seckel syndrome (SCKL), a systemic disorder characterized by microcephalic primordial dwarfism. However, the mechanisms underlying its multi-organ manifestations remain poorly understood. To investigate this, we utilized two mouse models harboring patient-derived CEP152 variants, Cep152W105*/K897* and Cep152Q32P/Q32P. While our previous work focused on neurodevelopmental defects, here we systematically analyzed extra-neuronal phenotypes. We identified impaired spermatogenesis, characterized by defective mitosis and increased apoptosis in spermatogonia, as well as hematological abnormalities indicative of macrocytic anemia. In addition, we found reduced expression of Opalin, a gene involved in oligodendrocyte differentiation, and decreased numbers of Olig2-positive oligodendrocytes, suggesting broader glial deficits beyond recently characterized neuronal abnormalities. Collectively, our results highlight the role of CEP152 dysfunction in multi-systemic abnormalities of SCKL and provide an integrative view of its impact on both neuronal and extra-neuronal development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Neurobiology, Institute for Developmental Research, Aichi Developmental Disability Center, Kasugai 480-0392, Japan.
- Department of Tumor Pathology, Gifu University School of Medicine, Gifu 501-1194, Japan.
- Department of Cellular Pathology, Institute for Developmental Research, Aichi Developmental Disability Center, Kasugai 480-0392, Japan.
- Department of Neurochemistry, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
- Hirano General Hospital, Gifu 501-1192, Japan.
ORCID-Profile: Koki Ichihashi, Tohru Matsuki, Atsuo Nakayama, Koh-Ichi Nagata
Förderung
- Japan Society for the Promotion of Science
- Daiko Foundation
- Japan Foundation for Pediatric Research
- JSPS KAKENHI
Zitieren
APA
Hamada, N., Ichihashi, K., Matsuki, T., Iwamoto, I., Nakayama, A., Hara, A., & Nagata, K. I. (2026). Extra-Neurological Characterization of Seckel Syndrome-Model Mice Harboring CEP152 Variants. Cells, 15(13), 1148. https://doi.org/10.3390/cells15131148
Vancouver
Hamada N, Ichihashi K, Matsuki T, Iwamoto I, Nakayama A, Hara A, et al. Extra-Neurological Characterization of Seckel Syndrome-Model Mice Harboring CEP152 Variants. Cells. 2026;15(13):1148. doi:10.3390/cells15131148
BibTeX
@article{Hamada2026,
author = {Hamada, Nanako and Ichihashi, Koki and Matsuki, Tohru and Iwamoto, Ikuko and Nakayama, Atsuo and Hara, Akira and Nagata, Koh-Ichi},
title = {Extra-Neurological Characterization of Seckel Syndrome-Model Mice Harboring CEP152 Variants},
journal = {Cells},
year = {2026},
volume = {15},
number = {13},
pages = {1148},
doi = {10.3390/cells15131148}
}
EUVIMED